Further research indicated that miR-145 indirectly regulates the Akt pathway by directly targeting Integrin-Linked Kinase (ILK), and co-treatment with miR-143 and miR-145 synergistically inhibited cell growth in bladder cancer cells 105. The gene discussed is ILK; the disease is urinary bladder carcinoma.